IRIDIAN ASSET MANAGEMENT LLC/CT - CONCERT PHARMACEUTICALS INC ownership

CONCERT PHARMACEUTICALS INC's ticker is CNCE and the CUSIP is 206022105. A total of 53 filers reported holding CONCERT PHARMACEUTICALS INC in Q4 2014. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
IRIDIAN ASSET MANAGEMENT LLC/CT ownership history of CONCERT PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2015$458,000
+26.2%
24,3920.0%0.00%
+33.3%
Q2 2015$363,000
+121.3%
24,392
+124.8%
0.00%
+200.0%
Q1 2015$164,000
+13.1%
10,8500.0%0.00%0.0%
Q4 2014$145,000
-19.4%
10,850
-24.0%
0.00%
-50.0%
Q3 2014$180,00014,2800.00%
Other shareholders
CONCERT PHARMACEUTICALS INC shareholders Q4 2014
NameSharesValueWeighting ↓
GREAT POINT PARTNERS LLC 2,200,000$37,532,0007.45%
BVF INC/IL 2,336,609$39,863,0006.78%
ISZO CAPITAL MANAGEMENT LP 152,988$2,610,0004.54%
SENZAR ASSET MANAGEMENT, LLC 416,845$7,111,0001.80%
INGALLS & SNYDER LLC 1,056,000$18,015,0000.96%
Lyon Street Capital, LLC 86,011$1,467,0000.59%
DRIEHAUS CAPITAL MANAGEMENT LLC 430,982$7,353,0000.25%
AWM Investment Company, Inc. 137,212$2,340,0000.22%
ACUTA CAPITAL PARTNERS, LLC 49,051$837,0000.20%
Schonfeld Strategic Advisors LLC 61,831$1,055,0000.11%
View complete list of CONCERT PHARMACEUTICALS INC shareholders